Drug "Proginova". Nyocha na Description

E bụ irè mmiri ọgwụ preparations na progesterone - a ọgwụ "Proginova". Nyocha Mee na-ekwu na ihe ndị mejupụtara nke ego dị estradiol valerate, nke bụ a sịntetik analọg nke mmadụ estradiol.

Mgbada n'usoro mmepụta nke endogenous estradiol emee n'oge menopause. Mgbe ụfọdụ, ya na usoro nke menopause, e nwere mgbanwe dị ịrịba ama na ego nke mmekọahụ homonụ na ọ bụghị naanị na-anapụta ndị erughị ala, ma na-ebelata n'ozuzu àgwà nke ndụ. Otú ọ dị, a nkọ ọnụ ke ego nke estrogen nwere ike ime ka thinning nke ọkpụkpụ anụ ahụ. Ọ bụ iji gbochie nsogbu ndị a na-emepụta ọgwụ gị n'ụlọnga "Proginova" e mepụtara. Consumer reviews na-egosi na ọgwụ si anagide ya aga-eme.

N'ihi ya, ihe oyiyi nke "Proginova" - a ọgwụ nke nwere a feminizing mmetụta ahụ na-enye mgbochi atherosclerotic na procoagulant mmetụta. A ọgwụ bụ ike nke na-akpali akpali mmepe nke fallopian akpa na akpanwa onwe ya, ikpu, stromal na ductal ara cancer. Amụ banyere ọgwụ ọjọọ, "Proginova" reviews, ị pụrụ ịhụ na ọ na-enyere aka normalize ọbara ọgbụgba mgbe nile na timeliness nke jụrụ endothermy.

na-agba akaebe

Ewere n'ime akaụntụ niile Njirimara nke ọgwụ na ọ na-e kenyere na ọrịa na:

• Oligominoreey.
• Gipomenoreey.
• Dysmenorrhea.
• Amenorrhea.
• Vaginitis.
• Estrogenic erughi jikọtara menopause ma ọ bụ ịwa ahụ menopause.
• Gipogenitalizme.
• Infertility.
• Post-menopausal osteoporosis.
• Virilnoe hypertrichosis.

Ndị mmadụ na-ekpe banyere ọgwụ ọjọọ, "Proginova 'nzaghachi gosiri na ọ ga-eji na post-okwu ime mgbe radieshon castration iji belata lactation n'oge na-adịghị ike ọrụ na dị ka a na nkà mmụta ọgwụ, iji na-akpali akpali hematopoiesis na radiative nnukwu lesion na mmadụ.

Nke a mmiri ọgwụ gị n'ụlọnga nwere ike ndinọ na prostate, ara ma ọ bụ akpati glands, urogenital ọrịa (atrophic vulvovaginitis, trine, dyspareunia, urethritis), maka ọgwụgwọ nke alopecia na hyperandrogenemia.

contraindications

N'etiti contraindications ọgwụ tọhapụ:

• Pregnancy.
• Mụbara uche.
• Genital ma ọ bụ eriri akpa nwa na-agba ọbara edoghị etiology.
• New estragenozavisimye malignancy na enyo na ha.
• N'ọrụ adọ nke thromboembolic ọrịa.

Ihe ókè na-elekọta ọgwụ kwesịrị iwere mgbe:

• Family hyperlipoproteinemia.
• Gallbladder ọrịa.
• Endometriosis.
• Hepatic porphyria.
• Pancreatitis.
• Siri ike hepatic insufficiency.
• Jaundice.
• Leiomyoma.
• Hypercalcemia na ọnụnọ nke ọkpụkpụ metastases;

mmetụta

Mmiri ọgwụ gị n'ụlọnga "Proginova" nwere ike ime ka ụfọdụ ekwesighi mmetụta: ọzịza, flatulence, pancreatitis, afọ ọsịsa, ịba ọcha n'anya, ọgbụgbọ, mgbochi nke gallbladder, isi ọwụwa, nsia ma ọ bụ biliary colic, dizziness, anorexia, ekweghị ibe nọrọ kpọtụrụ anya m, vomiting. Women nwere ike na-agba ọbara, intermenstrual agbapụta n'ahụ, soreness, dịkwuo libido, bloating ma ọ bụ ozizi nke mammary glands, menorrhagia, amenorrhea. Men nwere ike na-edebe soreness ma ọ bụ nro nke ara, genekomastiyu, ebelata libido.

Drug "Proginova" na ovulation

N'agbanyeghị eziokwu na ndị na-emepụta ọgwụ gị n'ụlọnga bụ a hormone, o nweghị mmetụta ovulation: emegbughị ya, na ihe fọrọ nke adịghị agbanwe arụmọrụ nke ego nke homonụ. Ọtụtụ mgbe, a ọgwụ kpọmkwem kenyere a ngwa ngwa ime. lee "Proginova" ọgwụ ọjọọ na "Djufaston" maka ndị a na nzube na-kenyere n'ụbọchị dị iche iche nke okirikiri. Nyocha nke ọtụtụ ndị inyom nwere gosiri irè nke usoro a nke ọgwụgwọ maka infertility.